Does ERDAFITINIB Cause Therapy cessation? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Therapy cessation have been filed in association with ERDAFITINIB (BALVERSA). This represents 1.4% of all adverse event reports for ERDAFITINIB.
15
Reports of Therapy cessation with ERDAFITINIB
1.4%
of all ERDAFITINIB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Therapy cessation From ERDAFITINIB?
Of the 15 reports, 1 (6.7%) required hospitalization.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ERDAFITINIB. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does ERDAFITINIB Cause?
Death (255)
Off label use (86)
Diarrhoea (75)
Stomatitis (58)
Fatigue (45)
Onycholysis (44)
Disease progression (41)
Dry mouth (41)
Nail disorder (40)
Hyperphosphataemia (39)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which ERDAFITINIB Alternatives Have Lower Therapy cessation Risk?
ERDAFITINIB vs ERENUMAB
ERDAFITINIB vs ERENUMAB-AOOE
ERDAFITINIB vs ERENUMAB\ERENUMAB-AOOE
ERDAFITINIB vs ERGOCALCIFEROL
ERDAFITINIB vs ERGOCALCIFEROL\PHYTONADIONE\RETINOL\TOCOPHEROL